The Future of Multiomic Analytical Instruments for Systems Biology

Closed Special Notice Posted

Solicitation number
IARPA-RFI-24-01
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Place of performance
Washington, District of Columbia 20511, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The Special Notice from the Intelligence Advanced Research Projects Activity (IARPA) seeks information on current and future multiomic analytical instruments capable of characterizing biomolecules in biological systems. IARPA aims to understand potential future concepts and multi-analyte platforms that can detect, identify, and characterize various biomolecules.

IARPA issued this Request for Information to inform potential program formulation, with responses due by January 12th, 2024. The RFI requests information on envisioned future instrument concepts, approaches to overcome variations and future-proof instruments, and multi-analyte detection platforms with discovery capabilities. All submissions must be provided electronically in PDF format to IARPA by the deadline. Eligible respondents include those able to provide insights on advances through incremental improvements or higher-risk research investments. Overall summaries of current state and future direction for analytical instruments are sought to aid IARPA planning efforts.

Notice text

IARPA is seeking information on the current state of the art (SOTA) and future direction of analytical instruments capable of detecting, identifying, and characterizing the multitude of biomolecules that constitute or are associated with biological systems and materials. Such molecules include but are not limited to the macromolecules of carbohydrates (saccharides or sugars), nucleic acids (DNA and RNA, canonical and non-canonical), proteins (amino acids, peptides, and fully functional protein or proteins), and lipids (fatty acids) as well as metabolites, other small molecules, and inorganic metals. This RFI is issued for planning purposes only and does not constitute a formal solicitation for proposals or suggest the procurement of any material, data sets, etc. 

IARPA recognizes and encourages the investments other entities are pursuing for improving single ‘omic’ or analyte characterization, especially focused on enabling improved single molecule sequencing of distinct analytes. IARPA’s mission is distinct from these entities with the mission to pursue even higher risk, higher impact activities and this RFI reflects IARPA’s interest in understanding what possible future capabilities may be achieved within a challenging concept space.  

IARPA seeks to understand potential future concepts and multi-analyte extensible instruments/analytical platforms able to detect, identify, and/or characterize the range of biomolecules and other elements associated with biological systems and materials. IARPA’s interests align with single modality, analyte extensible, platforms or instruments which can conceivably be integrated into a single workflow matching or exceeding current SOTA capabilities. Critically, IARPA seeks to understand what advances can be achieved with (i) incremental improvements to current capabilities and (ii) with investments towards higher-risk, further afield research which have not been proven.

Responses to this RFI are due no later than 5:00 p.m. 12 January 2024, Eastern Time. All submissions must be electronically submitted as a PDF document. Inquiries and submissions to this RFI must be submitted to DNI-IARPA-RFI-24-01@iarpa.gov. Do not send questions with proprietary content. No telephone inquiries will be accepted.

Files

File Type Posted
IARPA-RFI-24-01_Multiomic Instruments_C.pdf PDF

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity